Frovatriptan
- Level
- Commodity
- Parent
- 51142400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142408This classification denotes a serotonin agonist with the molecular formula C14H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H82Q2D5WA7, chemically known as 6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide but generally known as frovatriptan, which bears US NIH Compound Identifier 77992. European Medicines Agency schedules Frovatriptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07817MIG. The term FROVATRIPTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules frovatriptan in its Anatomical Therapeutic Chemical (ATC) Classification. FROVATRIPTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule frovatriptan under HS 29339990 and SITC 51577. As of Q4 2014, FROVATRIPTAN remains the US FDA Preferred Term for this commodity. Frovatriptan bears US NLM identifiers UMLS ID C0754647 and NCI Concept Code C65772. SMILES: O=C(N)C1CC2C3CC(NC)CCC3[NH]C2CC1.
Same parent
Under 51142400 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.